PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator(R) Device for Non-Invasive Treatment of ALS
PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator(R) Device for Non-Invasive Treatment of ALS GlobeNewswire January 12, 2026 BOSTON, MA and PROVIDENCE, RI, Jan. 12, 2026 (GLOBE NEWSWIRE) — PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease), today […]